ArticleUrologic oncology2022

Evaluation of post-ablation mpMRI as a predictor of residual prostate cancer after focal high intensity focused ultrasound (HIFU) ablation.

Yash S Khandwala et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.